Timeline

Lhousseine Touqui
Group Leader
14 Jun 2022
publication

Human peroxiredoxin 6 is essential for malaria parasites and provides a host-based drug target.

Read more
23 Feb 2022
project

Role of inflammatory mediators as predicting factors of COVID-19 pulmonary disease

Read more
15 May 2019
event

Cancelled (will be postponed) – Global Health Department Seminar “Molecular insights into host-pathogen reveals potential new therapeutic targets for MRSA and streptococci”

Read more
02 Jun 2018
project

Role of phospholipases A2 in lung inflammation

Read more
01 Mar 2018
event

“Immunomodulatory antimicrobial peptides: biology and applications” Infection & Epidemiology department seminar

Read more
17 Nov 2017
publication

High-Density Lipoproteins Exert Pro-inflammatory Effects on Macrophages via Passive Cholesterol Depletion and PKC-NF-κB/STAT1-IRF1 Signaling

Read more
18 Jul 2016
team

Cystic Fibrosis and Bronchial Diseases

Read more
04 Jul 2016
news

12th GERLI International LIPIDOMICS MEETING

Read more
22 Apr 2015
publication

Staphylococcus aureus Adenosine Inhibits sPLA2-IIA-Mediated Host Killing in the Airways

Read more
01 Mar 2015
publication

Host-microbe interactions in distal airways: relevance to chronic airway diseases

Read more
27 Nov 2014
publication

Cystic fibrosis bone disease: is the CFTR corrector C18 an option for therapy?

Read more
07 Oct 2014
publication

Pseudomonas aeruginosa eradicates Staphylococcus aureus by manipulating the host immunity

Read more
06 Sep 2014
publication

Cytosolic phospholipase A2α enhances mouse mortality induced by Pseudomonas aeruginosa pulmonary infection via interleukin 6

Read more
15 Mar 2014
publication

Cystic fibrosis and bone disease: defective osteoblast maturation with the F508del mutation in cystic fibrosis transmembrane conductance regulator

Read more
04 Mar 2014
publication

ZapE is a novel cell division protein interacting with FtsZ and modulating the Z-ring dynamics

Read more
04 Mar 2014
publication

Toll-like receptor 9 deficiency protects mice against Pseudomonas aeruginosa lung infection

Read more
30 Jul 2013
publication

Secreted group IIA phospholipase A2 protects humans against the group B streptococcus: experimental and clinical evidence

Read more
21 Mar 2013
publication

CFTR dysfunction induces vascular endothelial growth factor synthesis in airway epithelium

Read more
02 Jul 2012
publication

A crucial role of Flagellin in the induction of airway mucus production by Pseudomonas aeruginosa

Read more
01 Jul 2012
publication

Antisense inhibition of phospholipase A2: a new approach for already tested therapeutic targets for the treatment of sepsis*

Read more
22 Mar 2012
publication

A role for 12R-lipoxygenase in MUC5AC expression by respiratory epithelial cells

Read more
01 Mar 2012
publication

Influenza A induces the major secreted airway mucin MUC5AC in a protease-EGFR-extracellular regulated kinase-Sp1-dependent pathway

Read more
09 Nov 2011
publication

A novel bacterial resistance mechanism against human group IIA-secreted phospholipase A2: role of Streptococcus pyogenes sortase A

Read more
29 Apr 2010
publication

Cytosolic phospholipase A2alpha mediates Pseudomonas aeruginosa LPS-induced airway constriction of CFTR -/- mice

Read more
01 Dec 2003
publication

Interaction of secreted phospholipase A2 and pulmonary surfactant and its pathophysiological relevance in acute respiratory distress syndrome

Read more
01 Jun 2003
publication

Induction of type-IIA secretory phospholipase A2 in animal models of acute lung injury

Read more
01 Apr 2002
publication

Arachidonic acid differentially affects basal and lipopolysaccharide-induced sPLA(2)-IIA expression in alveolar macrophages through NF-kappaB and PPAR-gamma-dependent pathways

Read more
01 Apr 2002
publication

Effect of surfactant on pulmonary expression of type IIA PLA(2) in an animal model of acute lung injury

Read more